← Unusual insider activity · Company hub
INCY Incyte Genomics Inc
Insider figures are trailing 90 days, open-market Form 4 only. Institutional figures are the latest reported quarter. These windows are not simultaneous.
-$14.7M net selling - trailing 90 days
0 buyers - 3 unique sellers
Historical context: most recent complete month (2026-09) is the 23rd percentile of this ticker's monthly net P/S flow over 24 complete months. Lower percentiles are more selling; higher are more buying. P10–P90: -$7.7M to -$65K.
Institutional activity: not available - insufficient comparable institutions for the latest complete quarter.
open-market Form 4 only - grants, exercises, tax withholding excluded. ~ derived from SEC-reported shares x price.
Institutional activity: not available - insufficient comparable institutions for the latest complete quarter.
Who is responsible
| Insider | Role | Net activity | Rows |
|---|---|---|---|
| Mayes Patrick A | EVP & Chief Scientific Officer | -~$6.0M | 13 |
| CAGNONI PABLO J | President, Global Head of R&D | -~$5.9M | 4 |
| CAGNONI PABLO J | President, Global Head of R&D | -~$2.8M | 2 |
Transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| September 15, 2026 | CAGNONI PABLO J | President, Global Head of R&D | 2 reported sale rows | 23218 | — | ~$2.8M |
| September 15, 2026 | CAGNONI PABLO J | President, Global Head of R&D | S | -9233 | 120.5 | ~$1.1M |
| September 15, 2026 | CAGNONI PABLO J | President, Global Head of R&D | S | -13985 | 120.49 | ~$1.7M |
| August 19, 2026 | CAGNONI PABLO J | President, Global Head of R&D | S | -10801 | 125.56 | ~$1.4M |
| August 12, 2026 | CAGNONI PABLO J | President, Global Head of R&D | S | -10803 | 120.04 | ~$1.3M |
| August 5, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | S | -2207 | 123.99 | ~$0.3M |
| August 5, 2026 | CAGNONI PABLO J | President, Global Head of R&D | S | -10640 | 122.69 | ~$1.3M |
| August 3, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | S | -6055 | 120.43 | ~$0.7M |
| July 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | 11 reported sale rows | 41899 | — | ~$5.0M |
| July 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | S | -6171 | 119.43 | ~$0.7M |
| July 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | S | -4695 | 119.39 | ~$0.6M |
| July 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | S | -2864 | 119.4 | ~$0.3M |
| July 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | S | -1643 | 119.51 | ~$0.2M |
| July 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | S | -1642 | 119.38 | ~$0.2M |
| July 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | S | -85 | 122.19 | ~$10K |
| July 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | S | -326 | 121.69 | ~$40K |
| July 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | S | -2293 | 119.41 | ~$0.3M |
| July 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | S | -14661 | 119.46 | ~$1.8M |
| July 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | S | -5332 | 119.42 | ~$0.6M |
| July 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | S | -2187 | 119.47 | ~$0.3M |
| July 31, 2026 | CAGNONI PABLO J | President, Global Head of R&D | S | -15888 | 119.7 | ~$1.9M |
| July 16, 2026 | Stein Steven H | CMO & Head of Late-Stage Dev. | S | -1877 | 114.73 | ~$0.2M |
| July 16, 2026 | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | S | -1093 | 115.01 | ~$0.1M |
| July 15, 2026 | Stein Steven H | CMO & Head of Late-Stage Dev. | S | -28237 | 113.05 | ~$3.2M |
| June 4, 2026 | Tray Thomas | Principal Accounting Officer | S | -2639 | 100 | ~$0.3M |
| May 26, 2026 | Tray Thomas | Principal Accounting Officer | S | -2051 | 97.35 | ~$0.2M |
| May 19, 2026 | Clancy Paul J | — | S | -15000 | 94.93 | ~$1.4M |
| April 17, 2026 | CAGNONI PABLO J | President, Global Head of R&D | S | -18667 | 96.5 | ~$1.8M |
| March 17, 2026 | CAGNONI PABLO J | President, R&D | S | -18667 | 94.24 | ~$1.8M |
| February 19, 2026 | CAGNONI PABLO J | President, R&D | S | -18668 | 100.91 | ~$1.9M |
| January 7, 2026 | Issa Mohamed Khairie | EVP, Head of US Oncology | S | -10856 | 109.07 | ~$1.2M |
| January 5, 2026 | Stein Steven H | EVP & Chief Medical Officer | S | -15634 | 101.7 | ~$1.6M |
| December 19, 2025 | Tray Thomas | Principal Accounting Officer | S | -2774 | 100 | ~$0.3M |
| December 18, 2025 | Tray Thomas | Principal Accounting Officer | S | -600 | 98.25 | ~$59K |
| December 17, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | S | -4323 | 97.26 | ~$0.4M |
| December 16, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | 2 reported sale rows | 54008 | — | ~$5.3M |
| December 16, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | S | -53175 | 97.29 | ~$5.2M |
| December 16, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | S | -833 | 97.42 | ~$81K |
| December 11, 2025 | Mayes Patrick A | EVP & Chief Scientific Officer | S | -255 | 94.94 | ~$24K |
| December 10, 2025 | Mayes Patrick A | EVP & Chief Scientific Officer | S | -5553 | 95.58 | ~$0.5M |
| December 2, 2025 | Stein Steven H | EVP & Chief Medical Officer | S | -20105 | 102.51 | ~$2.1M |
| December 1, 2025 | Stein Steven H | EVP & Chief Medical Officer | S | -2559 | 102.96 | ~$0.3M |
| November 24, 2025 | Tray Thomas | Principal Accounting Officer | S | -600 | 103 | ~$62K |
| November 21, 2025 | Tray Thomas | Principal Accounting Officer | S | -169 | 102 | ~$17K |
| November 17, 2025 | Denton Sheila A. | EVP & General Counsel | S | -278 | 104.36 | ~$29K |
| November 10, 2025 | Hoppenot Herve | — | S | -187500 | 105.46 | ~$19.8M |
| November 5, 2025 | Stein Steven H | EVP & Chief Medical Officer | S | -5233 | 102.2 | ~$0.5M |
| November 4, 2025 | Denton Sheila A. | EVP & General Counsel | S | -598 | 101.36 | ~$61K |
| November 3, 2025 | Heeson Lee | EVP, Head of Incyte Intl | S | -3074 | 94.02 | ~$0.3M |
| October 15, 2025 | Denton Sheila A. | EVP & General Counsel | S | -277 | 85.13 | ~$24K |
| October 3, 2025 | Denton Sheila A. | EVP & General Counsel | S | -3501 | 85.54 | ~$0.3M |
| October 2, 2025 | Denton Sheila A. | EVP & General Counsel | S | -599 | 87.65 | ~$53K |
| September 16, 2025 | Denton Sheila A. | EVP & General Counsel | S | -278 | 83.15 | ~$23K |
| September 2, 2025 | Denton Sheila A. | EVP & General Counsel | S | -598 | 84.97 | ~$51K |
| August 15, 2025 | Denton Sheila A. | EVP & General Counsel | S | -277 | 86.81 | ~$24K |
| August 4, 2025 | Denton Sheila A. | EVP & General Counsel | S | -598 | 75.77 | ~$45K |
| July 21, 2025 | Stein Steven H | EVP & Chief Medical Officer | S | -3706 | 67.94 | ~$0.3M |
| July 16, 2025 | Denton Sheila A. | EVP & General Counsel | S | -785 | 68.36 | ~$54K |
| July 16, 2025 | Flannelly Barry P | EVP & General Manager US | S | -1340 | 68.36 | ~$92K |
| July 16, 2025 | Iyengar Vijay K | EVP, GMAPPS | S | -983 | 68.36 | ~$67K |
| July 15, 2025 | Iyengar Vijay K | EVP, GMAPPS | S | -1177 | 69.86 | ~$82K |
| July 15, 2025 | Flannelly Barry P | EVP & General Manager US | S | -1192 | 69.86 | ~$83K |
| July 15, 2025 | Denton Sheila A. | EVP & General Counsel | S | -3330 | 69.86 | ~$0.2M |
| July 14, 2025 | Stein Steven H | EVP & Chief Medical Officer | S | -14952 | 68.47 | ~$1.0M |
| July 3, 2025 | Iyengar Vijay K | EVP, GMAPPS | 2 reported sale rows | 8617 | — | ~$0.6M |
| July 3, 2025 | Iyengar Vijay K | EVP, GMAPPS | S | -5935 | 68.15 | ~$0.4M |
| July 3, 2025 | Iyengar Vijay K | EVP, GMAPPS | S | -2682 | 68.16 | ~$0.2M |
| July 3, 2025 | Flannelly Barry P | EVP & General Manager US | S | -10903 | 68.15 | ~$0.7M |
| July 2, 2025 | Denton Sheila A. | EVP & General Counsel | S | -599 | 68.61 | ~$41K |
| June 3, 2025 | Denton Sheila A. | EVP & General Counsel | S | -1795 | 68 | ~$0.1M |
| June 2, 2025 | Tray Thomas | Principal Accounting Officer | S | -651 | 64.88 | ~$42K |
| May 30, 2025 | Tray Thomas | Principal Accounting Officer | S | -963 | 65.71 | ~$63K |
| March 14, 2025 | Flannelly Barry P | EVP & General Manager US | 3 reported sale rows | 19807 | — | ~$1.3M |
| March 14, 2025 | Flannelly Barry P | EVP & General Manager US | S | -19147 | 67.68 | ~$1.3M |
| March 14, 2025 | Flannelly Barry P | EVP & General Manager US | S | -461 | 67.85 | ~$31K |
| March 14, 2025 | Flannelly Barry P | EVP & General Manager US | S | -199 | 67.88 | ~$14K |
| March 4, 2025 | Denton Sheila A. | EVP & General Counsel | S | -599 | 69.99 | ~$42K |
| February 26, 2025 | Denton Sheila A. | EVP & General Counsel | 2 reported sale rows | 14069 | — | ~$1.0M |
| February 26, 2025 | Denton Sheila A. | EVP & General Counsel | S | -4495 | 74.08 | ~$0.3M |
| February 26, 2025 | Denton Sheila A. | EVP & General Counsel | S | -9574 | 74.07 | ~$0.7M |
| January 21, 2025 | Stein Steven H | EVP & Chief Medical Officer | S | -12352 | 72.69 | ~$0.9M |
| December 16, 2024 | Tray Thomas | Principal Accounting Officer | S | -650 | 69.31 | ~$45K |
| December 13, 2024 | Tray Thomas | Principal Accounting Officer | S | -650 | 70.64 | ~$46K |
| November 29, 2024 | Iyengar Vijay K | EVP, GMAPPS | 2 reported sale rows | 6043 | — | ~$0.5M |
| November 29, 2024 | Iyengar Vijay K | EVP, GMAPPS | S | -360 | 75.6 | ~$27K |
| November 29, 2024 | Iyengar Vijay K | EVP, GMAPPS | S | -5683 | 75.37 | ~$0.4M |
| November 6, 2024 | Flannelly Barry P | EVP & General Manager US | 2 reported sale rows | 3680 | — | ~$0.3M |
| November 6, 2024 | Flannelly Barry P | EVP & General Manager US | S | -2256 | 78.21 | ~$0.2M |
| November 6, 2024 | Flannelly Barry P | EVP & General Manager US | S | -1424 | 82 | ~$0.1M |
| September 13, 2024 | Tray Thomas | Principal Accounting Officer | S | -382 | 63.37 | ~$24K |
| September 12, 2024 | Dickinson Jonathan Elliott | EVP, General Manager, Europe | 2 reported sale rows | 8450 | — | ~$0.5M |
| September 12, 2024 | Dickinson Jonathan Elliott | EVP, General Manager, Europe | S | -7333 | 62.37 | ~$0.5M |
| September 12, 2024 | Dickinson Jonathan Elliott | EVP, General Manager, Europe | S | -1117 | 62.3 | ~$70K |
| September 12, 2024 | Tray Thomas | Principal Accounting Officer | S | -572 | 62.94 | ~$36K |